Area of research
Cancer Research · Otorhinolaryngology
Research interest
Research interests include Head and Neck Cancer Studies, Cancer Genomics and Diagnostics, Chromatin Remodeling and Cancer, and Cancer-related molecular mechanisms research.
EGFR-mediated local invasiveness and response to Cetuximab in head and neck cancer
Balancing barriers: Family, career, and gender equality in radiation oncology and radiation research—An interdisciplinary prospective survey among the young workforce
Adjuvant (chemo)radiotherapy for patients with head and neck cancer: can comorbidity risk scores predict outcome?
Metabolic pathway-based subtypes associate glycan biosynthesis and treatment response in head and neck cancer
Systematic in vitro analysis of therapy resistance in glioblastoma cell lines by integration of clonogenic survival data with multi-level molecular data
A Novel Subgroup of UCHL1-Related Cancers Is Associated with Genomic Instability and Sensitivity to DNA-Damaging Treatment
DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score
Simultaneous metabolite MALDI-MSI, whole exome and transcriptome analysis from formalin-fixed paraffin-embedded tissue sections
DeepClassPathway: Molecular pathway aware classification using explainable deep learning
Integrative analysis of therapy resistance and transcriptomic profiling data in glioblastoma cells identifies sensitization vulnerabilities for combined modality radiochemotherapy
Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer Patients
Interferon-induced degradation of the persistent hepatitis B virus cccDNA form depends on ISG20
Early senescence and production of senescence-associated cytokines are major determinants of radioresistance in head-and-neck squamous cell carcinoma
Inhibition of HSP90 as a Strategy to Radiosensitize Glioblastoma: Targeting the DNA Damage Response and Beyond
Innovative radiation oncology Together – Precise, Personalized, Human
Tumor <scp>DNA‐methylome</scp> derived epigenetic fingerprint identifies <scp>HPV</scp>‐negative head and neck patients at risk for locoregional recurrence after postoperative radiochemotherapy
Enhanced root carbon allocation through organic farming is restricted to topsoils
Improved risk stratification in younger<i>IDH</i>wild-type glioblastoma patients by combining a 4-miRNA signature with<i>MGMT</i>promoter methylation status
PiggyBac transposon tools for recessive screening identify B-cell lymphoma drivers in mice
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes
A Five-MicroRNA Signature Predicts Survival and Disease Control of Patients with Head and Neck Cancer Negative for HPV Infection
Ionizing radiation biomarkers in epidemiological studies – An update